Clear All
12611 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
31722-0525-90 31722-0525 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Aug 1, 2010 In Use
70518-1704-02 70518-1704 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral May 26, 2026 In Use
68788-8433-03 68788-8433 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Apr 24, 2024 In Use
50090-1414-00 50090-1414 Finasteride Finasteride 1.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov 28, 2014 Apr 30, 2016 No Longer Used
52152-0500-30 52152-0500 Finasteride Finasteride Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Mar 28, 2007 Sep 30, 2013 No Longer Used
50090-1093-01 50090-1093 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Mar 4, 2016 Jan 31, 2018 No Longer Used
54868-5636-02 54868-5636 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Jun 30, 2006 In Use
51079-0321-56 51079-0321 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Jul 17, 2015 Dec 31, 2018 No Longer Used
50436-0446-03 50436-0446 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Aug 18, 2011 Dec 31, 2017 In Use
00093-7355-05 00093-7355 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Mar 14, 2008 Sep 30, 2026 In Use
50268-0314-15 50268-0314 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Jan 23, 2019 In Use
68645-0446-70 68645-0446 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Aug 1, 2010 Aug 31, 2018 No Longer Used
68645-0541-54 68645-0541 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Jun 13, 2015 In Use
70954-0652-10 70954-0652 Finasteride and Tadalafil Finasteride and Tadalafil 5.0 mg/1, 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Mar 24, 2025 In Use
70954-0652-20 70954-0652 Finasteride and Tadalafil Finasteride and Tadalafil 5.0 mg/1, 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Mar 24, 2025 In Use
69448-0009-63 69448-0009 Filgrastim-laha FILKRI 480.0 ug/.8mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous Jul 15, 2026 In Use
69448-0008-63 69448-0008 Filgrastim-laha FILKRI 300.0 ug/.5mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous Jun 29, 2026 In Use
69448-0008-03 69448-0008 Filgrastim-laha FILKRI 300.0 ug/.5mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous Jul 15, 2026 In Use
69448-0009-03 69448-0009 Filgrastim-laha FILKRI 480.0 ug/.8mL Ancillary Therapy Immunostimulant Granulocyte Colony-Stimulating Factor Intravenous, Subcutaneous Jul 15, 2026 In Use
54868-4151-00 54868-4151 Letrozole Femara 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral Feb 10, 2005 In Use
00078-0249-15 00078-0249 Letrozole Femara 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral Jul 31, 1997 In Use
83831-0143-01 83831-0143 Fluorouracil FAVLYXA 25.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Feb 20, 2026 In Use
83831-0164-10 83831-0164 Fluorouracil FAVLYXA 25.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jul 15, 2026 In Use
00310-0720-50 00310-0720 Fulvestrant Faslodex 50.0 mg/mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular May 20, 2002 Oct 31, 2015 In Use
00310-0720-25 00310-0720 Fulvestrant Faslodex 50.0 mg/mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular Nov 1, 2010 Sep 21, 2010 In Use

Found 12611 results — Export these results